knowcompoundsyohimbine
Specimen compoundPlate I
Yohimbine

- ChEBI
- CHEBI:10093
- PubChem CID
- 8969
↑ raised 5 findings in 3 endpoints · – no difference found 3 in 2
01 · the evidence, ordered
What the evidence says
- Strong
- 0
- Moderate
- 7
- Limited
- 1
- Very limited
- 0
- Insufficient
- 0
Yohimbine
Most findings
- Cortisol concentration×3
- Diastolic blood pressure×2
- Systolic blood pressure×2
- Working memory performance×1
36 compounds on the outer ring, not drawn
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
- Cortisol concentrationcontested
- Diastolic blood pressure
- Systolic blood pressure
- Working memory performance
02 · contested · 1 endpoint
Where the findings disagree
013 findings
Cortisol concentration
03 · findings
What yohimbine moved, and by how much
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
8 shown
- Diastolic blood pressureMoved: raisesEvidence: Moderatereplicated ×1Paper: PMID 231610012013An author is affiliated with a producer
- Who
- heroin-dependent volunteers not seeking treatment, maintained on buprenorphine 8 mg/day, inpatient; yohimbine 16.2 and 32.4 mg pooled against placebo pretreatment, before any hydromorphone was given on the session
- Dose studied
- yohimbine 16.2 mg and 32.4 mg orally, single dose per session at 9:30 AM, against placebo capsules of lactose
Yohimbine significantly increased systolic blood pressure ≈15 mmHg (η2 = 0.67) and diastolic blood pressure ≈10 mmHg (η2 = 0.61).”
Quoted verbatim from Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals.crossoverPermalink - Systolic blood pressureMoved: raisesEvidence: Moderatereplicated ×1Paper: PMID 235592222013An author is affiliated with a producer
- Who
- 23 healthy adult volunteers without Axis I or II disorder or hypertension, 10 men and 13 women; repeated measures over 180 minutes after a single dose, against placebo
- Dose studied
- yohimbine 0.4 mg/kg orally (mean 30.2 mg, range 21.6-43.2 mg) single dose, against matching placebo, counterbalanced order
Table 2 also shows that yohimbine significantly increased systolic blood pressure, diastolic blood pressure, and pulse rate.”
Quoted verbatim from Norepinephrine and impulsivity: effects of acute yohimbine.crossoverPermalink - Cortisol concentrationcontestedMoved: no difference foundEvidence: Moderatereplicated ×1Paper: PMID 389029282024
- Who
- healthy young men in a 2x2 factorial design; yohimbine main effect, with hydrocortisone given in half of the yohimbine and half of the placebo participants · n = 165
- Dose studied
- yohimbine 10 mg oral, given 120 min before the resting-state scan
We found no significant main effect of yohimbine on salivary cortisol (F(1, 161) = 0.04, p = 0.83, η2 = 0.00).”
Quoted verbatim from Effects of stress-related neuromodulators on amygdala and hippocampus resting state functional connectivity.RCTPermalink - Diastolic blood pressureMoved: raisesEvidence: Moderatereplicated ×1Paper: PMID 235592222013An author is affiliated with a producer
- Who
- 23 healthy adult volunteers without Axis I or II disorder or hypertension, 10 men and 13 women; repeated measures over 180 minutes after a single dose, against placebo
- Dose studied
- yohimbine 0.4 mg/kg orally (mean 30.2 mg, range 21.6-43.2 mg) single dose, against matching placebo, counterbalanced order
Table 2 also shows that yohimbine significantly increased systolic blood pressure, diastolic blood pressure, and pulse rate.”
Quoted verbatim from Norepinephrine and impulsivity: effects of acute yohimbine.crossoverPermalink - Working memory performanceMoved: no difference foundEvidence: ModeratePaper: PMID 325830132020
- Who
- healthy adults (55 of 121 female); 20 mg and 40 mg yohimbine arms against placebo, in all three controllability conditions (controllability, uncontrollability, no-shock), with the controllability manipulation spread across drug arms · n = 121
- Dose studied
- yohimbine 20 mg or 40 mg oral, single dose, against placebo
For our main dependent variable, the change in accumulated n-back level from baseline to post-manipulation, we observed strong evidence in favor of a lack of noradrenergic effects on working memory (session × noradrenergic manipulation: BFinclusion = 0.086).”
Quoted verbatim from (Lack of) Effects of noradrenergic stimulation on human working memory performance.RCTPermalink - Cortisol concentrationcontestedMoved: no difference foundEvidence: Moderatereplicated ×1Paper: PMID 381234642024
- Who
- healthy young men in a 2x2 factorial design; yohimbine main effect, with hydrocortisone given in half of the yohimbine and half of the placebo participants · n = 165
- Dose studied
- yohimbine 10 mg oral, given about two hours before resting-state scanning
There was no effect of yohimbine on salivary cortisol: F(1, 161) = 0.04, P = 0.83, η2 = 0.00.”
Quoted verbatim from No changes in triple network engagement following (combined) noradrenergic and glucocorticoid stimulation in healthy men.RCTPermalink - Systolic blood pressureMoved: raisesEvidence: Moderatereplicated ×1Paper: PMID 231610012013An author is affiliated with a producer
- Who
- heroin-dependent volunteers not seeking treatment, maintained on buprenorphine 8 mg/day, inpatient; yohimbine 16.2 and 32.4 mg pooled against placebo pretreatment, before any hydromorphone was given on the session
- Dose studied
- yohimbine 16.2 mg and 32.4 mg orally, single dose per session at 9:30 AM, against placebo capsules of lactose
Yohimbine significantly increased systolic blood pressure ≈15 mmHg (η2 = 0.67) and diastolic blood pressure ≈10 mmHg (η2 = 0.61).”
Quoted verbatim from Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals.crossoverPermalink - Cortisol concentrationcontestedMoved: raisesEvidence: LimitedPaper: PMID 291268572018
- Who
- cocaine-dependent women with low or high plasma progesterone, pooled; within-subject crossover on consecutive days around cocaine-cue exposure, smokers given a nicotine patch on both days
- Dose studied
- yohimbine 21.6 mg in a capsule, single dose at 12:00 on one study day, matching placebo capsule on the other, randomised counterbalanced order
Administration of yohimbine produced significant increases in salivary cortisol levels as compared to placebo (Yohimbine – Placebo Δ=0.17±0.02, F1,20=47.0, p<0.001; Figure 2A).”
Quoted verbatim from Impact of endogenous progesterone on reactivity to yohimbine and cocaine cues in cocaine-dependent women.crossoverPermalink
No row matches these filters.
No dose is advised.
- Dose studied: as its paper gave it.
- Evidence strength: computed from the study. How it is computed
- Industry funding: named on its row.
04 · on the label · 292 products
Labelled products
Source: NIH DSLD · Ingredient: yohimbine · 292 products · Declared amount per serving: 0.1–56 mg
130 labels state an amount162 do not
- 'MericaRed, White & Boom Napalm Jalapeno Margarita3 mgper 9.25 gDSLD:332822
- 'Merica LabzF-Bomb Firecracker Candy3 mgper 8.5 gDSLD:278031
- AD Elite SeriesShredabull 2.0amount not statedper 1 capsuleDSLD:278029
- Advanced Nutrition SystemsIso Lean 3 Extremeamount not statedper 1 capsuleDSLD:180540
- Advanced Nutrition SystemsMethyl Drive 3.0amount not statedper 1 capsuleDSLD:180570
- Advantage PharmaceuticalsNoxySurge6 mgper 2 capsulesDSLD:36533
- ALLMAXYohimbine+ Rauwolscine3 mgper 1 capsuleDSLD:296149
- ALLMAX NUTRITIONRazor 8 Blast Powder Extreme Berry4.5 mgper 9.5 gDSLD:62378
- ALLMAX NUTRITIONRazor 8 Extreme Berry4.5 mgper 9.5 gDSLD:41578
- ALLMAX NUTRITIONRazor 8 Key Lime Cherry4.5 mgper 9.5 gDSLD:41585
- Alpha Elite PerformancePipe Hitter Blue RazPausinystalia yohimbe Bark Extract2.5 mgper 6.88 gDSLD:339373
- Alpha LionAlpha ShredderPausinystalia yohimbe8 mgper 3 capsulesDSLD:246867
Show the remaining 280Show the first 12
Label record: NIH Office of Dietary Supplements · CC0
05 · the record
Sources
41
papers screened for yohimbine
- admitted
- 8
- read and discarded
- 16
- not read yet
- 17
- Documented interactions
- None reported
Sources cited
6 papers · 8 findings
2 admitted at screening, no finding yet